Cancer treatment and monitoring methods using OX40 agonists
摘要
<p>OX40 is a potent immune stimulating target. Provided herein are methods for the treatment of cancer patients using (3X40 agonists methods to predict clinical outcome of the treatment by correlation of the treatment and an increase in OX40-induced T cell proliferation.</p>
申请公布号
AU2012369202(A1)
申请公布日期
2014.09.25
申请号
AU20120369202
申请日期
2012.02.06
申请人
PROVIDENCE HEALTH & SERVICES - OREGON D/B/A PROVIDENCE PORTLAND MEDICAL CENTER
发明人
CURTI, BRENDAN;KOVACSOVICS-BANKOWSKI, MAGDALENA;WALKER, ED;WALKER, JOSH;WEINBERG, ANDY
